Calyxt, Inc. Stock Nasdaq
Equities
CBUS
US17166A1016
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 2.17M | Sales 2025 * | 8.69M | Capitalization | 319M |
---|---|---|---|---|---|
Net income 2024 * | -82M | Net income 2025 * | -88M | EV / Sales 2024 * | 147 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 36.7 x |
P/E ratio 2024 * |
-4.86
x | P/E ratio 2025 * |
-6.31
x | Employees | 183 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.22% |
Latest transcript on Calyxt, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Wade King
DFI | Director of Finance/CFO | 67 | - |
Peter Beetham
PSD | President | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Mark Finn
BRD | Director/Board Member | 81 | - |
Keith Walker
BRD | Director/Board Member | 76 | - |
1st Jan change | Capi. | |
---|---|---|
+6.02% | 215B | |
+9.25% | 187B | |
+19.58% | 143B | |
+29.74% | 110B | |
+1.48% | 64.68B | |
+15.27% | 52.96B | |
+2.69% | 49.84B | |
-5.47% | 38.32B | |
+1.58% | 35.86B |